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INTRODUCTION
Due to the increased availability of high-through-
put DNA-sequencing technologies and quantitative 
PCR, investigators have flooded the scientific liter-
ature with reports describing the composition of 
different gastrointestinal microbiotas. With the use 
of gnotobiotic isolators housing axenic animals, i.e. 
germ- or microbiota-free animals, investigators have 
also undertaken more hypothesis-driven research 
addressing putative roles for the microbiota in host 
health. Possibly inspired by the patent spread and 
pathogenesis of obesity and metabolic syndrome, in 
combination with the observation that a commonly 
used strain of germ-free laboratory mice are more 
resistant to obesity than their conventional coun-
terparts,1 a major focus of much of this work has 
considered the relationship between the microbi-
ota of the host and the susceptibility of the host to 
obesity. Additionally, compared to many existing 
and theoretic therapeutics to counter the obesity 
pandemic, the microbiota is potentially a more 
practical target. I attempt to very briefly summa-
rize, for nonprofessionals of microbiome study, 
the composition of the microbiota as it relates to 
obesity in humans. This is intended to provide the 
reader with sources for finding further information, 
including primary research that has contributed to 
our knowledge and more comprehensive reviews 
on the relevant topics mentioned.
COMPOSITION OF THE OBESE 
MICROBIOTA
Rejecting the Bacteroidetes: Firmicutes 
ratio 
Bacterial 16S DNA sequencing of stool samples 
from obese and non-obese individuals has revealed 
significant differences in their respective microbi-
otas.2-7 Indeed, the microbiota isolated from obese 
individuals is commonly designated as “dysbiotic,” 
a term meaning microbial imbalance or abnormal 
microbiota. However, how the microbiota is abnor-
mal is not at all well understood, largely because 
what makes a healthy microbiota is not well under-
stood. A frequently reported measure describ-
ing the microbiota is the ratio of Bacteroidetes 
to Firmicutes, two phyla that represent the most 
abundant bacterial species in human stool.8,9 More 
often, a decreased ratio—where Bacteroidetes are 
under-represented and Firmicutes are over-rep-
resented—is reported in obesity compared to 
healthy-weight controls,6,10-12 yet some reports have 
identified an increased ratio of Bacteroidetes to 
Firmicutes.5,13 Still others have reported an increase 
in the abundance of both phyla in the microbiota 
of obese individuals,14 while additional studies 
have found no association between the abundance 
of Bacteroidetes nor Firmicutes in the microbiotas 
of obese and healthy-weight individuals.4,9,15 Thus, 
the actual significance of the relative abundance of 
the two phyla, which are composed of thousands of 
distinct bacterial species, is extremely controversial. 
For a more comprehensive review of the members 
of Bacteroidetes and their connections to obesity, 
see Johnson et al.16
Diversity is not created equally
Most commonly, and perhaps less controversially, 
the microbiota of obese individuals is described as 
having reduced bacterial diversity. Of course, how 
diversity is calculated and reported is not entirely 
consistent, but certain trends have emerged, partic-
ularly the obese microbiota exhibiting reduced 
richness, a measure of α-diversity (within a single 
sample) which signifies the number of unique 
microbial species.4,7 For instance, in a fairly large 
study of nearly 600 American adults, Peters et  al 
observed that the richness of the microbiota of obese 
individuals was significantly reduced compared 
to that of overweight (but not obese) and healthy-
weight participants. However, when accounting for 
the evenness of the microbial populations within 
each sample, differences in α-diversity failed to 
reach significance.4 Another fairly large study of 
approximately 300 Danish individuals found that 
the sampled microbiotas demonstrated a bimodal 
distribution with regard to richness.7 Significantly 
more individuals in the group with lower microbial 
richness were obese and showed increased markers 
of metabolic syndrome, e.g. increased serum leptin, 
triglycerides, and hyperinsulinemia. Furthermore, 
in both this and an accompanying study,17 micro-
bial genes for metabolic pathways associated with 
inflammatory stress and production of potentially 
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deleterious metabolites were proportionally 
increased in the microbiomes with decreased rich-
ness. Interestingly though, when comparing the 
microbiomes of obese and non-obese individuals, 
fewer differences were identified than when the 
groups were divided based on microbial richness.7 
Other metrics that can be incorporated into 
measures of diversity, arguably more valuable 
than richness or evenness alone, include microbial 
phylogeny18 and function.19 Phylogenetic diver-
sity takes into account the degree of evolutionary 
relatedness of the resident microbiota. Several 
studies already mentioned account for microbial 
phylogeny when determining the diversity of the 
population.3,6-9,20 Importantly, increased diversity, 
as measured by 16S DNA, does not simply signify 
a “healthy microbiota”. Functional diversity, on 
the other hand, considers the entire microbial 
genome, the microbial transcriptome, proteome 
and/or other microbial-derived metabolites, i.e. 
the functional collective of the entire microbiome. 
Significant findings concerning the basic behav-
ioral interactions between members of the micro-
biota, e.g. reinforcing microbiota stability through 
microbial interactions, are based on transcriptome 
or metabolome profiles.21-23 It is fairly intuitive to 
appreciate how increased functional diversity may 
represent a healthier gut ecosystem. For example, 
functional diversity and redundancy may enable 
better adaptation to changes in physiology,24,25 
diet,9,26 or exposures to medication.27 Indeed, even 
though a small study of 25-32 year old twin pairs 
and their mothers revealed the gut microbiotas 
of obese individuals were more similar to each 
other than the similarity of microbiotas of lean 
participants to each other, no apparent overlap of 
phylotypes amongst microbial samples emerged. 
Instead, distinct functional cores, representing key 
metabolic pathways, emerged between the microbi-
omes of obese individuals compared to non-obese 
individuals.3 
“Specie-fic” differences that are real and 
reproducible?
So far the distinction between the microbi-
ota compositions of the obese compared to the 
non-obese is a matter of reduced number, evenness, 
relatedness, and/or function of the resident species. 
Summarizing the relevance of specific microbial 
differences is complicated by the finding that micro-
bial community variations between studies tend to 
be much greater than between obese and non-obese 
groups within studies.28,29 In addition, sampling 
biases and insufficient sequencing depths impact 
how well microbial samples accurately represent 
their true ecosystems, and rarefaction performed in 
order to make comparisons across studies further 
impacts the accuracy of sampled data. One poten-
tially more conserved gut microbial phenotype 
correlated with individuals who are obese or have 
low microbial richness is increased abundance 
of the less dominant phylum Proteobacteria.4,7,20 
Although not a specific observation, members of 
several comprising genera, e.g. Escherichia and 
Salmonella, represent potential human pathogens.30 
This is potentially relevant because obesity is also 
associated with increased inflammation; thus, 
many have investigated the role of the microbiota in 
obesity-related inflammation (reviewed by McPhee 
and Schertzer).31 Alternatively, Dao et  al found 
that increased or high abundance of Akkermansia 
muciniphila (in addition to overall microbial 
richness) in overweight and obese subjects after 
six weeks on a calorie restricted diet was associated 
with improved metabolic profiles.32 Importantly, A. 
muciniphila has been identified by several inves-
tigators as a species capable of conferring protec-
tion against obesity and metabolic disorders in 
animals,33-36 so the case for an effective probiotic is 
arguably best-made in support of A. muciniphila.37 
Despite the paucity of more specific, reproducible 
microbial associations with the obese phenotype, 
some studies have demonstrated that obese and 
lean human fecal microbiotas can transfer those 
phenotypes to animals,38-40 demonstrating that 
perhaps a variety of microbiota compositions may 
impact susceptibility to obesity. Additional research 
with animal models has provided significantly 
more insight into the composition and role of the 
gut microbiota in obesity and metabolic syndrome, 
as well as revealed possible mechanisms supporting 
their relationship,1,6,41-47 but how well the results 
from animal studies reflect the gut microbiota and 
obesity in humans is still unknown. 
CONCLUSION
In spite of the large amount of available data 
describing microbial associations with human 
obesity, microbial-related mechanisms that impact 
host metabolism, and the transmissibility of 
obesity, especially in animal-to-animal models, 
there are no clear obesogenic microbiota pheno-
types. Indeed, few compositional characteristics of 
the obese microbiotas considered herein appeared 
to be conserved across different studies, with the 
possible exception of some measure of reduced 
diversity compared to the non-obese microbiotas. It 
seems as though future work may unravel distinct, 
organism-independent, microbial functions that, 
when combined with certain dietary inputs or 
physiological aspects of the host, may enhance 
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susceptibility to obesity. Beyond the scope of this 
commentary, but critical to the understanding of a 
putatively obesogenic microbiota, is the irrefutable 
role of diet on the composition and metabolism 
of the microbiota, as well as on the metabolism of 
the host (reviewed by Sonnenburg and Backhed).48 
Naturally, what we feed ourselves directly impacts 
what we feed our microbiota, and the functional 
metabolic pathways expressed by the resident 
microbiota will influence which organisms can 
flourish with those dietary inputs and what micro-
biota-derived metabolites are produced. Future 
work describing the compositional and functional 
variation that is possible across different healthy 
microbiotas, as well as compositional and/or func-
tional similarities conserved across different healthy 
microbiotas, should provide a better platform for 
investigating, and eventually understanding, the 
abnormal character of a “dysbiotic” microbiota, as 
it relates to any human pathology. 
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